ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

Clinical trial NCT06328738 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06328738
Sponsor: Enliven Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-positive Breast Cancer HER2-positive Gastric Cancer HER2 Positive Solid Tumors HER2 Amplification Colorectal Cancer

Start date: 2024-05-30
Primary completion: 2027-01-01
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.